Features of the course and eradication of multidrug-resistant Pseudomonas aeruginosa infection in cystic fibrosis: clinical case

Features of the course and eradication of multidrug-resistant Pseudomonas aeruginosa infection in cystic fibrosis: clinical case

Chronic lung infection caused by Pseudomonas aeruginosa reduces respiratory function and life expectancy in people with cystic fibrosis. Up to 2/3 of hospitalized patients, have antibiotic-resistant strains of Pseudomonas aeruginosa, which presents significant difficulties in prescribing eradication...

Full description

Bibliographic Details
Main Authors:	E. I. Kondratyeva, E. V. Loshkova, E. D. Nikolaeva, M. M. Khachiyan, G. N. Yankina
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2021-10-01
Series:	Медицинский совет
Subjects:	cystic fibrosis pseudomonas aeruginosa inhaled antibiotics pulmonary exacerbations nutritional status vitamin d deficiency
Online Access:	https://www.med-sovet.pro/jour/article/view/6475

Similar Items

The emergence of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis patients on inhaled antibiotics
by: Atqah AbdulWahab, et al.
Published: (2017-01-01)

Role of inhaled antibiotics in children and adolescents with cystic fibrosis: Experience from the tertiary care center
by: Danish Abdul Aziz, et al.
Published: (2022-01-01)

Effectiveness of a multistep Pseudomonas aeruginosa eradication treatment protocol in children with cystic fibrosis in Brazil
by: Barbara Riquena, et al.
Published: (2020-07-01)

In vitro activity of cefiderocol against Pseudomonas aeruginosa isolated from cystic fibrosis patients
by: Marguerite L. Monogue, et al.
Published: (2023-12-01)

Antibiotic Susceptibility of Pseudomonas Aeruginosa Isolated from Cystic Fibrosis Patients
by: Soltan Dallal, MM, et al.
Published: (2015-01-01)

Detection of Morphotyping Characteristics Identification Antibiotic Resistance of Pseudomonas aeruginosa Isolated from Patients with Cystic Fibrosis
by: Hossein Fazeli, et al.
Published: (2012-03-01)

THE PREVALENCE OF PSEUDOMONAS AERUGINOSA STRAINS IN INFANTS WITH CYSTIC FIBROSIS WITHIN A HOSPITAL IN NORTH EASTER OF ROMANIA
by: Oana Alexandra Ciocan, et al.
Published: (2016-11-01)

CD14 C-159T and early infection with <it>Pseudomonas aeruginosa </it>in children with cystic fibrosis
by: Sly PD, et al.
Published: (2005-06-01)

Phenotypic characterization and PCR-Ribotypic profile of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Iran
by: Hossein Fazeli, et al.
Published: (2013-01-01)

Catabolism of Nucleic Acids by a Cystic Fibrosis Pseudomonas aeruginosa Isolate: An Adaptive Pathway to Cystic Fibrosis Sputum Environment
by: Sheemal Shanista Kumar, et al.
Published: (2019-05-01)

Physiological levels of nitrate support anoxic growth by denitrification of Pseudomonas aeruginosa at growth rates reported in cystic fibrosis lungs and sputum
by: Laura eLine, et al.
Published: (2014-10-01)

Interaction between Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis
by: Jingming Zhao, et al.
Published: (2018-11-01)

Bdellovibrio bacteriovorus directly attacks Pseudomonas aeruginosa and Staphylococcus aureus Cystic fibrosis isolates
by: Valerio eIebba, et al.
Published: (2014-06-01)

Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives
by: Giovanni Taccetti, et al.
Published: (2021-03-01)

Life in the cystic fibrosis upper respiratory tract influences competitive ability of the opportunistic pathogen Pseudomonas aeruginosa
by: Jeffrey J. Bara, et al.
Published: (2018-01-01)

Impact of concomitant nontuberculous mycobacteria and Pseudomonas aeruginosa isolates in non-cystic fibrosis bronchiectasis
by: Hsieh MH, et al.
Published: (2018-08-01)

Antibiotic duration and changes in FEV1 are not associated with time until next exacerbation in adult cystic fibrosis: a single center study
by: Julia C. Espel, et al.
Published: (2017-11-01)

Comparison of virulence factors and antibiotic resistance of Pseudomonas aeruginosa strains isolated from patients with and without cystic fibrosis
by: Macin Salih, et al.
Published: (2017-10-01)

Tipificación molecular de aislamientos de Pseudomonas aeruginosa obtenidos de pacientes con fibrosis quística Molecular typification of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis
by: N. G. Iglesias, et al.
Published: (2008-03-01)

Genomic and Functional Characterization of Longitudinal Pseudomonas aeruginosa Isolates from Young Patients with Cystic Fibrosis
by: Courtney E. Chandler, et al.
Published: (2023-08-01)

Multidrug-resistant Pseudomonas aeruginosa from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime–avibactam
by: Atkin SD, et al.
Published: (2018-09-01)

Cystic Fibrosis Patients Infected With Epidemic Pseudomonas aeruginosa Strains Have Unique Microbial Communities
by: Nicole Acosta, et al.
Published: (2020-04-01)

Competition in Biofilms between Cystic Fibrosis Isolates of <italic toggle="yes">Pseudomonas aeruginosa</italic> Is Shaped by R-Pyocins
by: Olubukola Oluyombo, et al.
Published: (2019-02-01)

Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo
by: YongTao Li, et al.
Published: (2017-07-01)

Delafloxacin––A novel fluoroquinolone for the treatment of ciprofloxacin‐resistant Pseudomonas aeruginosa in patients with cystic fibrosis
by: Beverley Cherie Millar, et al.
Published: (2021-01-01)

Adaptation and genomic erosion in fragmented Pseudomonas aeruginosa populations in the sinuses of people with cystic fibrosis
by: Catherine R. Armbruster, et al.
Published: (2021-10-01)

Evaluation of type IV pilin sub groups in Pseudomonas aeruginosa isolated from environmental samples, cystic fibrosis and burn patients
by: Alireza Salimi chirani, et al.
Published: (2014-10-01)

Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm
by: Arianna ePompilio, et al.
Published: (2015-09-01)

γδ T lymphocytes from cystic fibrosis patients and healthy donors are high TNF-α and IFN-γ-producers in response to <it>Pseudomonas aeruginosa</it>
by: Martínez Natalia, et al.
Published: (2003-09-01)

Pyoverdine-Dependent Virulence of Pseudomonas aeruginosa Isolates From Cystic Fibrosis Patients
by: Donghoon Kang, et al.
Published: (2019-09-01)

Activity of Delafloxacin and Comparator Fluoroquinolones against Multidrug-Resistant <i>Pseudomonas aeruginosa</i> in an In Vitro Cystic Fibrosis Sputum Model
by: Vaughn D. Craddock, et al.
Published: (2023-06-01)

Quantitative Framework for Model Evaluation in Microbiology Research Using <italic toggle="yes">Pseudomonas aeruginosa</italic> and Cystic Fibrosis Infection as a Test Case
by: Daniel M. Cornforth, et al.
Published: (2020-02-01)

Antimicrobial Activity of α-Peptide/β-Peptoid Lysine-Based Peptidomimetics Against Colistin-Resistant Pseudomonas aeruginosa Isolated From Cystic Fibrosis Patients
by: Natalia Molchanova, et al.
Published: (2019-02-01)

Adapting to the Airways: Metabolic Requirements of <i>Pseudomonas aeruginosa</i> during the Infection of Cystic Fibrosis Patients
by: Ruggero La Rosa, et al.
Published: (2019-10-01)

Persistence and Microevolution of Pseudomonas aeruginosa in the Cystic Fibrosis Lung: A Single-Patient Longitudinal Genomic Study
by: Irene Bianconi, et al.
Published: (2019-01-01)

Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs—A Review
by: Ana Margarida Sousa, et al.
Published: (2014-08-01)

To bead or not to bead: A review of Pseudomonas aeruginosa lung infection models for cystic fibrosis
by: Nicole Reyne, et al.
Published: (2023-02-01)

Interactions between Neutrophils and Pseudomonas aeruginosa in Cystic Fibrosis
by: Balázs Rada
Published: (2017-03-01)

Bile effects on the Pseudomonas aeruginosa pathogenesis in cystic fibrosis patients with gastroesophageal reflux
by: Mobina Bayat, et al.
Published: (2023-11-01)

Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis
by: Anna S. Tai, et al.
Published: (2017-11-01)